Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Low Risk

Score: 25/100

Failure Rate

0.0%

0 terminated/withdrawn out of 6 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

33%

2 trials in Phase 3/4

Results Transparency

0%

0 of 1 completed trials have results

Key Signals

1 recruiting

Enrollment Performance

Analytics

Phase 3
2(66.7%)
Phase 1
1(33.3%)
3Total
Phase 3(2)
Phase 1(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (6)

Showing 6 of 6 trials
NCT05302531Phase 1Recruiting

Absorption of Antibiotics With High Oral Bioavailability in Short-bowel Syndrome

Role: collaborator

NCT04390633Unknown

Perception of Needs of Patients With Chronic Intestinal Failure and Their Practitioners: a Qualitative Study

Role: collaborator

NCT04150302Unknown

Development and Validation of a Questionnaire to Measure the Impact of SBS and Its Treatments on Patients' Lives

Role: collaborator

NCT03482895Completed

MINI Bypass Versus Roux-en-Y Bypass: Differences in HOrmonal Secretions at 2 Years of Surgery

Role: collaborator

NCT02418065Phase 3Unknown

Multimodal Therapeutic Approach in Undernourished Maintenance Hemodialysis Patients (AMERICANO)

Role: collaborator

NCT01955772Phase 3Unknown

Randomized, Prospective, Multicenter Study to Compare Enteral Nutrition to Parenteral Nutrition as Feeding Support in Patients Presenting Malignant Hemopathy Who Underwent an Allogeneic Hematopoietic Stem Cell Transplantation.

Role: collaborator

All 6 trials loaded